Are analysts right about CONMED Corporation (CNMD)?

Health Care · price $50.32 · median target $40.00 (-20%)

In short — Over the past 12 months, 18% of analyst price targets on CONMED Corporation turned out profitable, for an average return of -14% (across 62 timestamped calls). The current consensus is "Hold" with a median price target of $40.00 (-20% vs the current $50.32, from 5 analysts).

📈 See the interactive version (live chart) →

🔗 Related pages on CONMED Corporation — Financials & fundamentals · If I had invested

Current price

$50.32

Median target (12 mo)

$40.00 -20%

Analyst accuracy (1 yr)

18%

Avg return / call (1 yr)

-14%

💰 Performance & « if I invested » 📊 Interactive analysis

Historical analyst accuracy

For CONMED Corporation, we replayed every analyst price target of the past 12 months and measured the real outcome: 18% were profitable, average return -14% (62 calls). At 3 months: -2% average return (30% profitable). The higher the %, the more often analysts were right on this stock.

Most reliable analysts on this stock (past track record)

Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.

Analyst / broker	Calls i	% profitable i	Avg return i
Needham	23	17%	-21%
Piper Sandler	11	18%	-9%
Stifel	10	30%	+1%
JP Morgan	5	20%	+2%

Frequently asked questions

Is CONMED Corporation a buy right now?

The analyst consensus on CONMED Corporation (CNMD) is "Hold" (1 bullish, 1 bearish calls over 12 months). This is not advice: historically, 18% of their targets on this stock turned out profitable over 1 year.

What is CONMED Corporation's price target?

The median 12-month price target is $40.00 (-20% vs $50.32), ranging from $36.00 to $46.00 (5 analysts).

Are analysts accurate on CONMED Corporation?

Over 1 year, 18% of analyst targets on CONMED Corporation were profitable, for an average return of -14% (across 62 timestamped calls). This is JPI Invest's accuracy metric.

What is the CONMED Corporation stock forecast?

Analysts target a median of $40.00 within 12 months, i.e. -20% vs the current price. The most bullish targets $46.00, the most cautious $36.00.

What is the CONMED Corporation stock forecast for 2026 or long term (2030)?

Note: analyst targets are 12-month (median $40.00, -20%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (18%), and the stock's past trajectory.

Is CONMED Corporation overvalued?

Detailed valuation data for CONMED Corporation is available in the interactive analysis.

📊 See the full interactive analysis of CONMED Corporation →

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
💬 AI assistant: ask anything about any stock, with the numbers
📊 Portfolio tracking + 🔔 price alerts by email

Explore JPI Invest for free → How it works: the method →

⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.